LVMH Moët Hennessy - Louis Vuitton (MC)
Euronext Paris · France · prices in EUR · close of 22 Oct 2026
Key indicators
| Last close | EUR 387.80 |
|---|---|
| 52-week range | 375.65 – 654.70 |
| Return, 1 month / 3 months | −3.5% / −18.2% |
| Return, 1 year / 3 years | −36.2% / −37.6% |
| Trend | Below its 200-day average |
| RSI (14) | 42 |
| Volatility (1 year) | 27.2% |
| Worst drawdown (1 year) | -41.0% |
| Average daily value traded | 231.46M EUR |
| Dividend yield | 3.4% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
LVMH Moët Hennessy - Louis Vuitton is a French luxury goods group based in Paris. It designs and sells fashion and leather goods through houses such as Louis Vuitton and Christian Dior, and produces champagne, cognac and other spirits through brands including Moët & Chandon and Hennessy. The group also operates in watches and jewellery, perfumes and cosmetics, and selective retailing, serving affluent customers in markets around the world through its own stores and specialist retailers.
On this site LVMH Moët Hennessy - Louis Vuitton appears as a stock on the Euronext Paris (France), code MC, with prices in euros (EUR). Our dividend records, which start in 2019, show payments in 8 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
LVMH Moët Hennessy - Louis Vuitton (MC) trades on the Euronext Paris in France. It last closed at EUR 387.80 on 22 October 2026.
Its price-based Market X-Ray is 50 out of 100 (a fair price profile), ranking 325 of 625 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price fell 36.2% and over the last three months it fell 18.2%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on Euronext Paris
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 28 · Weak | Below its long-term averages and far from its highs. | |
| Above 200-day average | -18.1% | ||
| From 52-week high | -40.5% | ||
| Momentum | 28 · Weak | Lagging most stocks on this exchange. | |
| 3-month return | -18.2% | ||
| 6-month return | -16.9% | ||
| 12-month return, skipping the last month | -33.9% | ||
| Stability (higher is calmer) | 59 · Fair | Typical risk for this exchange. | |
| Volatility, 1 year (lower is calmer) | 27.2% | ||
| Worst drawdown, 1 year (smaller is calmer) | -41.0% | ||
| Liquidity | 100 · Strong | Trades actively. | |
| Average daily value traded | 231.46M EUR | ||
| Zero-volume days | 0.0% | ||
| Income | 69 · Fair | Dividend is typical for this exchange. | |
| Dividend yield | 3.4% | ||
| Years with dividends | 6 |
Strengths
- Liquidity: Trades actively.
Weak spots
- Trend: Below its long-term averages and far from its highs.
- Momentum: Lagging most stocks on this exchange.
Returns
| 1 week | −2.6% |
|---|---|
| 1 month | −3.5% |
| 3 months | −18.2% |
| 6 months | −16.9% |
| 1 year | −36.2% |
| 3 years | −37.6% |
| 5 years | −36.0% |
Signals
| 50-day / 200-day average | 413.47 / 473.50 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 8.56 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 1 Dec 2026 | EUR 5.5000 |
| 28 Apr 2026 | EUR 7.5000 |
| 2 Dec 2025 | EUR 5.5000 |
| 24 Apr 2025 | EUR 7.5000 |
| 2 Dec 2024 | EUR 5.5000 |
| 23 Apr 2024 | EUR 7.5000 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Euronext Paris; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.